https://www.selleckchem.com/pr....oducts/pyrotinib.htm
ates that providing OLP and enhancing the encounter remotely is possible, but their effectiveness might be lower in comparison to previous studies relying on physical patient-provider interaction. The study raises questions for future research about the potential and challenges of remote placebo studies and virtual clinical encounters. The study has been registered as a clinical trial at ISRCTN (record number 39018).Content addition to courses and its subsequent correct sequencing in a study plan or curricula design context determine
Like
Comment
Share
